Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

Details 詳細情報について

• CRID

  1360580236804076928

• DOI

  10.1007/s40264-022-01194-z

• ISSN

  11791942

  01145916

• Web Site

  https://link.springer.com/content/pdf/10.1007/s40264-022-01194-z.pdf

  https://link.springer.com/article/10.1007/s40264-022-01194-z/fulltext.html

• Data Source

  • Crossref